HALOZYME THERAPEUTICS, INC. Repayments of Long-term Lines of Credit
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermLinesOfCredit · last filed 2025-02-18
- HALOZYME THERAPEUTICS, INC. repayments of long-term lines of credit for the quarter ending 2023-12-31 was $0.00.
- HALOZYME THERAPEUTICS, INC. repayments of long-term lines of credit for the quarter ending 2022-12-31 was $0.00.
- HALOZYME THERAPEUTICS, INC. repayments of long-term lines of credit for the quarter ending 2021-12-31 was $0.00.
- HALOZYME THERAPEUTICS, INC. repayments of long-term lines of credit for fiscal 2024 was $0.00.
- HALOZYME THERAPEUTICS, INC. repayments of long-term lines of credit for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- HALOZYME THERAPEUTICS, INC. repayments of long-term lines of credit for fiscal 2022 was $120.00M.
- HALOZYME THERAPEUTICS, INC. repayments of long-term lines of credit for fiscal 2021 was $0.00.
| Period end | Repayments of Long-term Lines of Credit 3 month | Repayments of Long-term Lines of Credit 9 month | Repayments of Long-term Lines of Credit 12 month |
|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-18 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $0.00 10-K · filed 2025-02-18 | |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-06 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $120.00M 10-K · filed 2025-02-18 | |
| 2022-09-30 | $120.00M 10-Q · filed 2023-11-06 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $0.00 10-K · filed 2024-02-20 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-08 | ||
| 2020-12-31 | $0.00 10-K · filed 2023-02-21 |